The treatment of hospital wastewater: An appraisal

Journal of Water and Health

Volumn 4, Issue 4, 2006, Pages 405-416

  Pauwels, B ^a   Verstraete, Willy ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Estrogen; Hospital wastewater; Multiple antibiotic resistance; Wastewater treatment; X ray contrast media

Indexed keywords

ACTIVATED CARBON; CARBAMAZEPINE; CHLORINE; CIPROFLOXACIN; CISPLATIN; CLOFIBRIC ACID; CODEINE; DIATRIZOATE; DRINKING WATER; ERYTHROMYCIN; ESTROGEN; ETHINYLESTRADIOL; GADOLINIUM; GENTAMICIN; IFOSFAMIDE; INDIUM; IOMEPROL; IOPROMIDE; MERCURY; METICILLIN; METRONIDAZOLE; OFLOXACIN; OSMIUM; PARACETAMOL; PLATINUM; SULFAMETHOXAZOLE; SURFACE WATER; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG;

ANTHROPOGENIC EFFECT; CHEMICAL POLLUTANT; DRINKING WATER; PUBLIC HEALTH; WASTE TREATMENT; WASTEWATER;

ADSORPTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AQUATIC ENVIRONMENT; ARTICLE; BACTERIAL STRAIN; BIODEGRADATION; BIOREACTOR DESIGN; CHLORINATION; CONTROLLED STUDY; DISINFECTION; ECOTOXICITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FOOD CHAIN; GENOTOXICITY; HOSPITAL WASTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; OZONATION; PHOTOLYSIS; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH SERVICE; REVERSE OSMOSIS; SEPARATION TECHNIQUE; SEWER; ULTRAVIOLET RADIATION; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

EID: 33845400389     PISSN: 14778920     EISSN: None     Source Type: Journal    
DOI: 10.2166/wh.2006.0024     Document Type: Article

References (76)

1. Adams, C., Wang, Y., Loftin, K. & Meyer, M. 2002 Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng. 128(3), 253-260.
2. Aksu, Z. & Tunç, Ö. 2004 Application of biosorption for penicillin G removal: comparison with activated carbon. Process Biochem. 40(2), 831-847.
3. Andersen, H., Siegrist, H., Halling-Sorensen, B. & Ternes, T. A. 2003 Fate of estrogens in a municipal sewage treatment plant. Environ. Sci. Technol. 37(18), 4021-4026.
4. Anderson, P., D'Aco, V., Shanahan, P., Chapra, S., Buzby, M., Cunningham, V., Duplessie, B., Hayes, E., Mastroco, F., Parke, N., Rader, J., Samuelian, J. & Schwab, B. 2004 Screening analysis of human pharmaceutical compounds in US surface waters. Environ. Sci. Technol. 38(3), 838-849.
5. Andreozzi, R., Raffaelle, M. & Nicklas, P. 2003 Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50, 1319-1330.
6. Balcioǧlu, I. & Ötker, M. 2003 Treatment of pharmaceutical wastewater containing antibiotics by O3 and O3/H2O2 processes. Chemosphere 50, 85-95.
7. Baronti, C., Curini, R., D'Ascenzo, G., Gentili, A. & Samperi, R. 2000 Monitoring natural and synthetic oestrogens at activated sludge sewage treatment plant and in a receiving river water. Environ. Sci. Technol. 34(24), 5059-5066.
8. Blanch, A. R., Caplin, J. L., Iversen, A., Kühn, I., Manero, A., Taylor, H. D. & Vilanova, X. 2003 Comparison of enterococcal populations related to urban and hospital wastewater in various climatic and geographic European regions. J. Appl. Microbiol. 94, 994-1002.
9. Carballa, M., Omil, F., Lema, J. M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M. & Ternes, T. 2004 Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Wat. Res. 38, 2918-2926.
10. Chitnis, V., Chitnis, S., Vaidiya, K., Ravikant, S., Patil, S. & Chitnis, D. S. 2004 Bacterial population changes in hospital effluent treatment plant in central India. Wat. Res. 38, 441-447.
11. Cizman, M., Beovic, B., Krcmery, V., Barsic, B., Tamm, E., Ludwig, E., Pelemis, M., Karovski, K., Grzesiowski, P., Gardovska, D., Volokha, A., Keuleyan, E., Stratchounski, L., Dumitru, C., Titov, L. P., Usonis, V. & Dvorak, P. 2004 Antibiotic policies in Central Eastern Europe. Int. J. Antimicrob Agric. 24, 1-6.
12. Clara, M., Strenn, B., Ausserleitner, M. & Kreuzinger, N. 2004 Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Wat. Sci. Technol. 50(5), 29-36.
13. Cyr, P. J., Suri, R. P. S. & Helmig, E. D. 2002 A pilot scale evaluation of removal of mercury from pharmaceutical wastewater using granular activated carbon. Wat. Res. 36, 4725-4734.
14. Daughton, C. G. & Ternes, T. A. 1999 Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Persp. 107(6), 907-938.
15. D'Ascenzo, G., Di Corcia, A., Gentili, A., Mancini, R., Mastropasqua, R., Nazzari, M. & Samperi, R. 2003 Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci. Total Environ. 302, 199-209.
16. Debska, J., Kot-Wasik, A. & Namiesnik, J. 2004 Fate and analysis of pharmaceutical residues in the aquatic environment. Crit. Rev. Anal. Chem. 34(1),51-67.
17. De Rudder, J., Van de Wiele, T., Dhooge, W., Comhaire, F. & Verstraete, W. 2004 Advanced water treatment with manganese oxide for the removal of 17α-ethinylestradiol (EE2). Wat. Res. 38, 184-192.
18. de With, K., Bergner, J., Bühner, R., Dörje, F., Gonnermann, C., Haber, M., Hartmann, M., Rothe, U., Strehl, E., Steib-Bauert, M. & Kern, W. V. 2004 Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II). Int. J. Antimicrob Agric. 24, 15-20.
19. Doll, T. & Frimmel, F. H. 2003 Fate of pharmaceuticals - photodegradation by simulated solar UV-light. Chemosphere 52, 1757-1769.
20. Emmanuel, E., Keck, G., Blanchard, J. M., Vermande, P. & Perrodin, Y. 2004 Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater. Environ. Int. 30(7), 891-900.
21. Engels-Matena, U. 1996 Der Abbau von iodierten Röntgenkontrastmiteln durch den Weißfäulepilz Trametes versicolor. Germany. PhD thesis. University of Hamburg-Harburg, 145 (in English).
22. Ferguson, P., Iden, C., McElroy, A. & Brownawell, B. 2001 Determination of steroid estrogens in wastewater by immunoaffinity extraction with HPLC-electrospray MS. Anal. Chem. 73(16), 3890-3895.
23. Ferrari, B., Paxeus, N., Lo Giudice, R., Pollio, A. & Garric, J. 2003 Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Safety 55, 359-370.
24. Fujimoto, S. 2004, Mitsubishi Rayon Co., Ltd. Personal communication, 22/ 10/2004.
25. Futselaar, H. 2004, Norit/X-Flow. Personal communication 15/10/2004.
26. Giger, W., Alder, A. C., Golet, E. M., Kohler, H. P., McArdell, C. S., Molnar, E., Siegrist, H. R. & Suter, M. 2003 Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters. Chimia 57, 485-491.
27. Göbel, A., McArdell, C. S., Suter, M. J. F. & Giger, W. 2004 Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry. Anal. Chem. 76(16), 4756-4764.
28. Guillaume, G., Verbrugge, D., Chasseur-Libotte, M. L., Moens, W. & Collard, J. M. 2000 PCR typing of tetracycline resistance determinants (Tet A-E) in Salmonella enterica serotype Hadar and in the microbial community of activated sludges from hospital and urban wastewater treatment facilities in Belgium. FEMS Microbiol. Ecol. 32, 77-85.
29. Hernando, M. D., Petrovic, M., Fernandez-Alba, A. R. & Barcelo, D. 2004 Analysis by liquid chromatography-electrospray ionization tandem mass spectrometry and acute toxicity evaluation for β-blockers and lipid-regulating agents in wastewater samples. J. Chromatogr. A 1046, 133-140.
30. Hirsch, R., Ternes, T. A., Haberer, K. & Kratz, K. L. 1999 Occurence of antibiotics in the aquatic environment. Sci. Total Environ. 225, 109-118.
31. Holbrook, R. D., Novak, J. T., Grizzard, T. J. & Love, N. G. 2002 Estrogen receptor agonist fate during wastewater and biosolids treatment processes: A mass balance analysis. Environ. Sci. Technol. 36, 4533-4539.
32. Hu, J., Cheng, S., Aizawa, T., Terao, Y. & Kunikane, S. 2003 Products of aqueous chlorination of 17β-estradiol and their estrogenic activities. Environ. Sci. Technol. 37, 5665-5670.
33. Huber, M. M., Canonica, S., Park, G. Y. & Von Gunten, U. 2003 Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37, 1016-1024.
34. Jolibois, B., Guerbet, M. & Vassal, S. 2003 Detection of hospital wastewater genotoxicity with the SOS chromotest and Ames fluctuation test. Chemosphere 51, 539-543.
35. Jones, O., Voulvoulis, N. & Lester, J. 2001 Human pharmaceuticals in the aquatic environment - a review. Environ. Technol. 22, 1383-1394.
36. Joss, A., Andersen, H., Ternes, T., Richle, P. R. & Siegrist, H. 2004 Removal of estrogens in Municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ. Sci. Technol. 38(11), 3047-3055.
37. Jung, R., Fish, D. N., Obritsch, M. D. & MacLaren, R. 2004 Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J. Hosp. Inf. 57, 105-111.
38. Kalsch, W. 1999 Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide. Sci. Total Environ. 225, 143-153.
39. Kamps, J. 2004, Kamps NV, representative of Zenon Environ. Inc. Personal communication, 30/09/2004.
40. Kerkman, E. 2004, Solis Engineering bv, representative of Kubota Corporation for Benelux. Personal communication, 11/10/2004.
41. Kimura, K., Amy, G., Drewes, J. E., Heberer, T., Kim, T. U. & Watanabe, Y. 2003 Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes. J. Membrane Sci. 227, 113-121.
42. Kolpin, D., Furlong, E. T., Meyer, M. T., Thurmann, E. M., Zaugg, S. D., Barber, L. B. & Buxton, H. T. 2002 Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36, 1202-1211.
43. Kümmerer, K. 2001 Drugs in the environment: emission of drugs, diagnostic aidsand disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 45, 957-969.
44. Kümmerer, K., Al-Ahmad, A. & Mersch-Sundermann, V. 2000 Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 40, 701-710.
45. Larsen, T. A., Lienert, J., Joss, A. & Siegrist, H. 2004 How to avoid pharmaceuticals in the environment. J. Biotechnol. 113, 295-304.
46. Lee, B. C., Kamata, M., Akatsuka, Y., Takeda, M., Ohno, K., Kamei, T. & Magara, Y. 2004 Effects of chlorine on the decrease of estrogenic chemicals. Wat. Res. 38, 733-739.
47. Liu, B. & Liu, X. 2004 Direct photolysis of estrogens in aqueous solutions. Sci. Total Environ. 320(2-3), 269-274.
48. McArdell, C. S., Molnar, E., Suter, M. J. F. & Giger, W. 2003 Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed, Switzerland. Environ. Sci. Technol. 37(24), 5479-5486.
49. Moriyama, K., Matsufuji, H., Chino, M. & Takeda, M. 2004 Identification and behavior of reaction products formed by chlorination of ethynylestradiol. Chemosphere 55, 839-847.
50. Ohlsen, K., Ternes, T., Werner, G., Wallner, U., Löffler, D., Ziebuhr, W., Witte, W. & Häcker, J. 2003 Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environ. Microbiol. 5(8), 711-716.
51. Onda, K., Nakamura, Y., Takatoh, C., Miya, A. & Katsu, Y. 2003 The behaviour of estrogenic substances in the biological treatment process of sewage. Wat. Sci. Technol. 47(9), 109-116.
52. Petrovic, M., Gonzalez, S. & Barcelo, D. 2003 Analysis and removal of emerging contaminants in wastewater and drinking water. TrAC 22(10), 685-696.
53. Purdom, C. E., Hardiman, P. A., Bye, V. J., Eno, N. C., Tyler, C. R. & Sumpter, J. P. 1994 Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 8(4), 275-285.
54. Reinthaler, F. F., Posch, J., Feierl, G., Wüst, G., Haas, D., Ruckenbauer, G., Mascher, F. & Marth, E. 2003 Antibiotic resistance of E. coli in sewage and sludge. Wat. Res. 37, 1685-1690.
55. Richardson, S. D. 2003 Disinfection by-products and other emerging contaminants in drinking water. TrAC 22(10), 666-684.
56. Ruiz, L., Dominguez, M. A., Ruiz, N. & Viñas, M. 2004 Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch. Med. Res. 35, 251-257.
57. Sacher, F., Lange, F. T., Brauch, H. J. & Blankenhorn, I. 2001 Pharmaceuticals in groundwaters - analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J. Chromatogr. A 938, 199-210.
58. Schäfer, A. & Nghiem, L. 2003 Removal of the natural hormone estrone from aqueous solutions using nanofiltrations and reverse osmosis. Environ. Sci. Technol. 37(1), 182-188.
59. Schwartz, T., Kohnen, W., Jansen, B. & Obst, U. 2003 Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and water biofilms. FEMS Microbiol. Ecol. 43, 325-335.
60. Snyder, S. A., Westerhoff, P., Yoon, Y. & Sedlak, D. L. 2003 Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Engng. Sci. 20(5), 449-469.
61. Stackelberg, P. E., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Henderson, A. K. & Reissman, D. B. 2004 Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 329, 99-113.
62. Steger-Hartmann, T., Länge, R., Schweinfurth, H., Tschampel, M. & Rebmann, I. 2002 Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium. Wat. Res. 36, 266-274.
63. Ternes, T. A. 1998 Occurence of drugs in German sewage treatment plants and rivers. Wat. Res. 32, 3245-3260.
64. Ternes, T. A. 2001 Analytical ethods the determination of pharmaceuticals in aqueous environmental samples. TrAC 20(8), 419-434.
65. Ternes, T. A., Kreckel, P. & Müller, J. 1999 Behaviour and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 225, 81-90.
66. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Haist-Gulde, B., Preuss, G., Wilme, U. & Zulei-Seibert, N. 2002 Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36(17), 3855-3863.
67. Ternes, T. A., Stüber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, M. & Teiser, B. 2003 Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Wat. Res. 37, 1976-1982.
68. Thomas, K., Hurst, M., Matthiessen, P. & Waldock, M. 2001 Characterization of estrogenic compounds in water samples collected from United Kingdom estuaries. Environ. Toxicol. Chem. 20(10), 2165-2170.
69. United States Commercial Service 2004 Membrane requirement in China. www.buyusa.gov/print/china/en/sarsl5.html, 05/06/2004.
70. van Elsas, J. D., Fry, J., Hirsch, P. & Molin, S. 2000 Ecology of plasmid transfer and spread. In: The Horizontal Gene Pool. Bacterial Plasmids and Gene Spread (ed. Thomas, C. M.), pp. 175-206. Harwood Academic, London.
71. Versweyveld, L. 2004 Europe's contrast media market strongly tied to medical imaging equipment industry. Virtual Medical Worlds Monthly. Available at: http://www.hoise.com/vmw/02/articles/vmw/ LV-VM-11-02-l.html.
72. Vilanova, X., Manero, A., Cerda-Cuellar, M. & Blanch, A. R. 2004 The composition and persistence of faecal coliforms and enterococcal population in sewage treatment plants. J. Appl. Microbiol. 96, 279-288.
73. Webb, S., Ternes, T. A., Gibert, M. & Olejniczak, K. 2003 Indirect human exposure to pharmaceuticals via drinking water. Toxicol. Lett. 142, 157-167.
74. Witters, H. E., Vangenechten, C. & Berckmans, P. 2001 Detection of estrogenic activity in Flemish surface waters using an in vitro recombinant assay with yeast cells. Wat. Sci. Technol. 43(2), 117-123.
75. Yang, S. & Carlson, K. 2004 Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique. Wat. Res. 38(14-15), 3155-3166.
76. Yoon, S.-H., Kim, H.-S. & Yeom, I.-T. 2004 The optimum operational condition of membrane bioreactor (MBR): cost estimation of aeration and sludge treatment. Wat. Res. 38, 37-46.